Risk of chemotherapy-induced amenorrhea in patients with breast cancer: a systematic review and meta-analysis
Authors:
- 22 April 2016
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 55 (6) , 664-670
Abstract
Background: The aim of the study was to calculate the rate of chemotherapy-induced amenorrhea (CIA) after treatment with different adjuvant therapies in patients with breast cancer and to evaluate the risk factors for CIA based on the quality of evidence. Patient and methods: A search of PubMed and ISI Web of Science was performed. All published trials with female breast cancer patients who received adjuvant chemotherapy and presented data on the rate of CIA were considered eligible. The pooled rates of CIA were calculated by random effects model. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated for each potential risk factor for CIA by using the generic inverse weighted method. Results: We identified 580 potentially relevant studies, of which 75 were included in the analysis. Among 75 eligible studies, 19 different definitions of CIA have been used. The pooled rate of CIA was 55% (95% CI 50–60%) including 23 673 patients from 74 studies. The rate of CIA was increased by age with an estimate of 26% (95% CI 12–43%), 39% (95% CI 31–58%), and 77% (95% CI 71–83%) for women 40 years old, respectively. Two risk factors were associated with the occurrence of CIA and were supported by strong level of evidence: older age (>40 years old), and the use of tamoxifen. Conclusions: This meta-analysis summarized the updated evidence on the impact of different adjuvant treatment regimens for breast cancer in menstruation and could serve as a helpful guide for oncologists during the discussion with their patients on fertility issues before decision on adjuvant therapy is made. A uniform definition of CIA is essential in future studies to make the interpretation of results more reliable.Keywords
This publication has 28 references indexed in Scilit:
- Impact of Fertility Concerns on Tamoxifen Initiation and PersistenceJNCI: Journal of the National Cancer Institute, 2015
- Prospective Study of Fertility Concerns and Preservation Strategies in Young Women With Breast CancerJournal of Clinical Oncology, 2014
- Fertility preservation in cancer survivors: a national survey of oncologists’ current knowledge, practice and attitudesBritish Journal of Cancer, 2013
- Breast cancer in young womenNature Reviews Clinical Oncology, 2012
- Fertility Preservation in Women Undergoing Treatment for Breast Cancer in the U.K.: A Questionnaire StudyThe Oncologist, 2012
- Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression ProfilingClinical Cancer Research, 2012
- Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trialsThe Lancet, 2012
- Quality of Life, Fertility Concerns, and Behavioral Health Outcomes in Younger Breast Cancer Survivors: A Systematic ReviewJNCI: Journal of the National Cancer Institute, 2012
- Oncologists’ Confidence in Knowledge of Fertility Issues for Young Women with CancerJournal of Cancer Education, 2012
- Web-Based Survey of Fertility Issues in Young Women With Breast CancerJournal of Clinical Oncology, 2004